On August 6, 2026, the first lockup expiration in SpaceX's post-IPO schedule freed up to roughly 911.5 million shares held by company insiders, allowing some investors to sell for the first time since the company's public debut Investopedia. The expiration could roughly triple the tradable public float in SPCX shares Reuters. By value, approximately $123 billion in stock became eligible to trade Investing.com.

SpaceX closed its initial public offering on June 15, 2026, raising gross proceeds of approximately $85 billion SpaceX IR. The IPO comprised 638,888,888 shares of Class A common stock in aggregate, with 555,555,555 shares offered at a public offering price of $135.00 per share. An additional 55,555,555 shares were registered under a separate EU prospectus at a maximum price of $162.00 per share. Shares trade on the Nasdaq Global Select Market under ticker SPCX SpaceX Q2 2026 Results.

The lockup release was not unconditional. SpaceX's stock was required to hold $175.50 or higher for five of ten consecutive trading days as part of the lockup terms — a price threshold mechanism designed to prevent insiders from selling into a declining market Investing.com. That condition was met, clearing the way for the August 6 release.

The staggered lockup schedule means today's expiration is the first of several. Additional tranches will free more shares through December 2026, raising the tradable float to 40% of total shares outstanding by year-end Reuters. By mid-2027, the schedule will have unlocked an additional 12.9 billion shares Reuters. The remaining 60% of shares, including Elon Musk's stake, will stay locked until that mid-2027 window Reuters. Musk himself is restricted from selling until 366 days after the IPO date Reuters.

Reuters reported that SPCX shares slipped on the lockup expiry day, adding to what the outlet characterized as post-IPO woes for the stock Reuters. No specific percentage decline or closing price was provided in the available reporting.

The mechanics here are worth parsing for what they imply about supply dynamics. A float that roughly triples overnight creates a structural overhang that has nothing to do with fundamentals. The market now has to absorb incremental sell pressure not from discretionary holders rebalancing, but from insiders whose cost basis is a fraction of the $135 offer price and who have been unable to monetize until this date. The price-gate condition — requiring SPCX to hold above $175.50 for five of ten sessions — gave a green light only after the stock demonstrated sufficient bid support. That means the supply hitting the tape now does so at a level the underwriters' lockup architects deemed acceptable. Whether that bid persists under several hundred million shares of newfound liquidity is the open question.

The staggered structure is the more consequential design choice. Rather than releasing all restricted shares in a single cliff expiration, SpaceX and its underwriters opted for a phased release that extends through mid-2027. This converts what would have been a single-day supply shock into a persistent overhang. For institutional investors running position models, this means the stock's effective float is a moving target. Each tranche expiry introduces a discrete step-up in free float that demands repricing of liquidity premiums, bid-ask depth assumptions, and portfolio weight ceilings. Models that treat lockup expiry as a one-time event will systematically misprice the drag.

The 12.9 billion shares set to unlock by mid-2027 dwarfs the 911.5 million freed today. That figure is orders of magnitude larger than the IPO's 638.9 million Class A share offering, suggesting the vast majority of SpaceX's equity was retained by insiders, founders, and early investors rather than sold into the public market. The slow-release structure means this supply will bleed into the market over roughly twelve months rather than cascading in a single session. Investors evaluating SPCX now face not just today's float expansion but a calendar of incremental dilution events stretching well into 2027, each requiring its own supply absorption test.